JPS63150208A - External drug for skin - Google Patents
External drug for skinInfo
- Publication number
- JPS63150208A JPS63150208A JP61295874A JP29587486A JPS63150208A JP S63150208 A JPS63150208 A JP S63150208A JP 61295874 A JP61295874 A JP 61295874A JP 29587486 A JP29587486 A JP 29587486A JP S63150208 A JPS63150208 A JP S63150208A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- genus
- juniperus
- dandruff
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title abstract description 11
- 229940079593 drug Drugs 0.000 title abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 44
- 241000218636 Thuja Species 0.000 claims abstract description 19
- 241000196324 Embryophyta Species 0.000 claims abstract description 16
- 241000721662 Juniperus Species 0.000 claims abstract description 13
- 241000218691 Cupressaceae Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims description 28
- 235000008109 Thuja occidentalis Nutrition 0.000 claims description 17
- 208000001840 Dandruff Diseases 0.000 abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 9
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 8
- 206010000496 acne Diseases 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 abstract description 8
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 241000736892 Thujopsis dolabrata Species 0.000 abstract description 2
- 241000736890 Thujopsis Species 0.000 abstract 2
- 230000005722 itchiness Effects 0.000 abstract 2
- 241000233866 Fungi Species 0.000 abstract 1
- 240000005308 Juniperus chinensis Species 0.000 abstract 1
- 241000448458 Juniperus procumbens Species 0.000 abstract 1
- 244000162475 Juniperus rigida Species 0.000 abstract 1
- 235000009069 Juniperus rigida Nutrition 0.000 abstract 1
- 235000008215 Juniperus rigida var conferta Nutrition 0.000 abstract 1
- 244000207931 Juniperus rigida var. conferta Species 0.000 abstract 1
- 241000030601 Thuja standishii Species 0.000 abstract 1
- 230000000855 fungicidal effect Effects 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 238000000605 extraction Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000008213 purified water Substances 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 235000015961 tonic Nutrition 0.000 description 6
- 230000001256 tonic effect Effects 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000007803 itching Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000011022 opal Substances 0.000 description 5
- 210000004761 scalp Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- -1 1,3 butylene Chemical group 0.000 description 4
- 241000186427 Cutibacterium acnes Species 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 241001464974 Cutibacterium avidum Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229940055009 propionibacterium avidum Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000605059 Bacteroidetes Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000588767 Proteus vulgaris Species 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000887462 Thujopsis dolabrata var. hondae Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229940007042 proteus vulgaris Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 230000008417 skin turnover Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明はヒノキ科アスナロ属、クロベ属又はビヤクシン
属に属する植物の抽出物を含有してなる、医薬品、医薬
部外品、化粧品等の皮膚外用剤に関する。[Detailed Description of the Invention] [Industrial Application Field] The present invention relates to skin products such as pharmaceuticals, quasi-drugs, and cosmetics containing extracts of plants belonging to the Cupressaceae family, the genus Asunaro, the genus Arborvitae, or the genus Juniper. Regarding external preparations.
[従来の技術]
シップヒバ、アスナロ、クロベ等のヒノキ科の植物は、
環境汚染などに対し比較的抵抗力が強い植物である。[Conventional technology] Plants of the cypress family, such as ship hiba, asunaro, and arborvitae, are
It is a plant that is relatively resistant to environmental pollution.
ヒノキ科ヒノキ属のシップシバにはビシフェリン酸、0
−メチルビシフニリン酸等のジテルペンが含有され、こ
れらの物質に抗菌活性があることが見出された(例えば
「香料、テルペンおよび精油化学に関する討論会」昭和
59年度講演要旨集シップヒバの抗菌活性成分;小林孝
次、西野親生)。しかしその抗菌活性はダラム陰性腸内
細菌(プロテウス ブルガリス: Proteus v
u1gari゛S)、グラム陽性黄色ブドウ状球菌、枯
草菌等に属することが報告されているに過ぎず、アクネ
及びフケ、カユミなどの原因菌に対する報告はみられな
い。Biciferic acid, 0
- Contains diterpenes such as methylbisifuniphosphate, and these substances were found to have antibacterial activity (e.g., "Seminar on Fragrances, Terpenes, and Essential Oil Chemistry", 1985 Lecture Abstracts, Antibacterial Activity of Shiphiba) Ingredients: Koji Kobayashi, Chikao Nishino). However, its antibacterial activity is limited to Durham-negative enterobacteria (Proteus vulgaris).
It has only been reported that it belongs to bacteria such as U1gari゛S), Gram-positive Staphylococcus aureus, and Bacillus subtilis, and there have been no reports on the causative bacteria of acne, dandruff, itching, etc.
また、同じヒノキ科でも他のアスナロ属、クロベ属、ビ
ヤクシン属にはこの種の報告は見当らない。Furthermore, no reports of this species have been found in the other genera Asunaro, Arborvitae, and Juniper within the Cupressaceae family.
[発明が解決しようとする問題点]
本発明者等は上記した事情に鑑み、アクネ、及びフケ、
カユミなどの抑制に有効な成分を開発することを目的と
して研究を進めている過程で、植物またはその抽出物の
抗菌活性、体臭抑制効果について鋭意研究を重ねた結果
、ヒノキ科アスナロ属、クロベ属又はビヤクシン属に属
する植物の抽出物にアクネ(尋常性浸そう:Acne
vulgaris)の原因菌とされるグラム陽性嫌気性
細菌であるプロピオニバクテリウムアクネス(Prop
ionibacterium acnes)及び頭皮の
フケ、カユミの原因菌とされる頭皮常在酵母ビテイロス
ポラムオパール(Pityrosporum oval
e)に対し有効な抗菌力を示すことを見出した。またこ
の抗菌力を示すものは、前記したシップシバに含まれる
ビシフェリン酸とは全く事なるものであることも確認し
た。これらのことは、従来の報告には全く示唆されてお
らず、本発明者等が初めて見出したところのものであり
、本発明者らはこれらの知見にもとづいて本発明を完成
するに至った。[Problems to be solved by the invention] In view of the above circumstances, the present inventors have solved acne, dandruff,
In the process of conducting research with the aim of developing ingredients that are effective in suppressing itchy skin, we have conducted extensive research into the antibacterial activity and body odor suppressing effects of plants and their extracts. Alternatively, extracts of plants belonging to the genus Juniperina can be used to treat acne (acne vulgaris).
Propionibacterium acnes (Prop.
ionibacterium acnes) and the scalp resident yeast Viteirosporum opal (Pityrosporum oval), which is thought to be the cause of scalp dandruff and itching.
It has been found that it exhibits effective antibacterial activity against e). It has also been confirmed that the substance exhibiting this antibacterial activity is completely different from the biciferic acid contained in the above-mentioned shipshiba. These matters have not been suggested in any previous reports, and were discovered for the first time by the present inventors.Based on these findings, the present inventors have completed the present invention. .
すなわち、本発明はヒノキ科アスナロ属、りaべ属また
はビヤクシン属に属する植物の抽出物を含有してなる皮
膚外用剤を提供するものである。That is, the present invention provides an external skin preparation containing an extract of a plant belonging to the Cupressaceae family, the genus Asunaro, the genus Riabe, or the genus Juniper.
以下に本発明の構成について詳述する。The configuration of the present invention will be explained in detail below.
本発明に用いる植物はヒノキ科アスナロ属、クロベ属、
又はビヤクシン属に属する植物で、具体的にはアスナロ
属のアスナロ、アテ、またはヒノキアスナロ、クロベ属
のクロベ、ビヤクシン属のネズ、ハイネズ、イブキ、ハ
イビヤクシン、またはミャマビャクシン等があげられる
。The plants used in the present invention include Cupressaceae, Asunaro genus, Arborvitae genus,
Or a plant belonging to the Juniper genus, specifically, Asunaro, Ate, or Hinoki Asunaro of the Asuna genus, Arborvitae of the Arborvitae genus, Junniper juniper of the Juniper genus, Japanese juniper, Japanese juniper, Japanese juniper, or Myanthia juniper.
本発明においてはこれらの植物の抽出物の形で用いられ
る。抽出物を製造するにおいては植物抽出物の常法が用
いられる。即ち、まず上記植物の葉または小枝を採取し
、そのまま又は乾燥後粉砕し粉砕物を得る。次いで該粉
砕物を後述する溶媒を用いて抽出する。葉は採取時期に
より抽出内容物の比が多少変化するものの、いずれの採
取期のものも使用可能である。抽出溶媒は、一般的に植
物抽出に用いられる溶媒ならば使用に制限はない。In the present invention, these plants are used in the form of extracts. In producing the extract, conventional methods for plant extracts are used. That is, first, leaves or twigs of the above-mentioned plants are collected and crushed as is or after drying to obtain a crushed product. Next, the pulverized product is extracted using a solvent described below. Although the ratio of extracted contents of leaves changes somewhat depending on the time of collection, leaves from any time of collection can be used. There are no restrictions on the use of the extraction solvent as long as it is a solvent commonly used for plant extraction.
ただし、溶媒の組合せによっては抽出内容物の比率が変
化したり、着色度に差が出るので、エタノール、プロピ
レンゲルコール、水、ヘキサン等が望ましい。抽出条件
は、一般的に植物抽出に用いられる条件ならば特に制限
はない。ただし葉の粉砕度合が抽出時間並びに抽出効率
に影響を与えるため、直径2mmの粒子を通過ぎせ得る
櫛にかけ、この櫛を通過した粉砕物を用いて行うのが望
ましい。抽出温度によっても抽出内容物の比率が変化す
るが特に制限はない。ただし香気成分をも得たい場合は
高温での揮散が懸念されるので避けるほうが望ましい。However, depending on the combination of solvents, the ratio of extracted contents may change or the degree of coloring may vary, so ethanol, propylene gelcol, water, hexane, etc. are preferable. Extraction conditions are not particularly limited as long as they are conditions commonly used for plant extraction. However, since the degree of pulverization of the leaves affects the extraction time and extraction efficiency, it is preferable to use a comb that can pass particles with a diameter of 2 mm and use the pulverized material that has passed through the comb. Although the ratio of extracted contents changes depending on the extraction temperature, there is no particular restriction. However, if you also want to obtain aroma components, it is preferable to avoid it because there is a concern that it will volatilize at high temperatures.
抽出溶媒量も特に制限はないが、抽出効率と濾過等の後
処理の容易ざから葉1部に対し抽出溶媒1部ないしは1
0部が最も望ましいO
本発明に用いる抽出物は、抽出したままの溶液で用いて
も、溶媒を留去して濃縮したエキスとして用いても良く
、また溶媒を完全に留去した高粘稠物あるいは粉末とし
て用いても良い。There is no particular restriction on the amount of extraction solvent, but for extraction efficiency and ease of post-processing such as filtration, it is recommended to use 1 part or 1 part of extraction solvent for 1 part of leaves.
0 parts is most desirable. It may be used as a substance or powder.
本発明の皮膚外用剤には、上述の方法等で得られた抽出
物を任意の量含有して良いが、通常、皮膚外用剤全量中
に、乾燥残分量として0.01〜10重量%含有されて
いるのが望ましく、さらに好ましくは0.1〜3重量%
がアクネ及びフケ、カユミ原因菌に対する抗菌力を示し
適当である。The skin external preparation of the present invention may contain any amount of the extract obtained by the above-mentioned method, etc., but it usually contains 0.01 to 10% by weight as a dry residue in the total amount of the skin external preparation. It is desirable that the content is 0.1-3% by weight, more preferably 0.1-3% by weight.
It is suitable because it shows antibacterial activity against bacteria that cause acne, dandruff, and itching.
本発明の皮膚外用剤には前記した抽出物に加えて、皮膚
外用剤基剤として、皮膚外用剤のタイプに応じて、油分
、水などを配合することができ、更に必要に応じて界面
活性剤、保湿剤、低級アル凶−ル、増粘剤、香料、酸化
防止剤、キレート剤、色素、防腐防黴剤などの皮膚外用
剤に用いられる慣用成分を配合することができる。In addition to the above-mentioned extracts, the external skin preparation of the present invention may contain oil, water, etc. as a base for the external skin preparation, depending on the type of the external skin preparation. Conventional ingredients used in external skin preparations such as agents, humectants, lower alcohols, thickeners, fragrances, antioxidants, chelating agents, pigments, and antifungal agents can be blended.
本発明の皮膚外用剤の剤型は任意であり、溶液系、可溶
化系、乳化系、粉末分散系、水−油二層系、水−油一粉
末三層系、どのような剤型でもかまわない。The dosage form of the skin external preparation of the present invention is arbitrary, and any dosage form may be used, including a solution type, solubilized type, emulsion type, powder dispersion type, water-oil two-layer type, water-oil and powder three-layer type. I don't mind.
また、本発明の皮膚外用剤の用途も任意であり、医薬品
、医薬部外品、化粧品、トイレタリー製品等に広く用い
られる。例えば化粧水、乳液、クリーム、パック、ヘア
トニック、ヘアクリーム、シャンプー、ヘアリンス、水
性軟膏、油性軟膏等があげられる。Further, the use of the skin external preparation of the present invention is arbitrary, and it is widely used in pharmaceuticals, quasi-drugs, cosmetics, toiletry products, etc. Examples include lotions, emulsions, creams, packs, hair tonics, hair creams, shampoos, hair rinses, aqueous ointments, oil-based ointments, and the like.
[実施例]
次に実施例をあげて本発明を更に具体的に説明するが、
本発明の範囲をこれ等の実施例に限定するものではない
ことはいうまでもない。なお以下の例において、配合量
は重量%で示す。[Example] Next, the present invention will be explained in more detail with reference to Examples.
It goes without saying that the scope of the present invention is not limited to these examples. In addition, in the following examples, the blending amount is shown in weight %.
調製例1
アスナロの葉と小枝をスピードミルにて粉砕し、直径2
mmの粒子を通過ぎせ得る櫛にかけて核部を通過した粉
砕物だけを集めた。次いで該粉砕物1部に対してエタノ
ール5部を加え、25〜35℃の室内で4週間抽出しガ
ラスフィルター濾過し、褐色の抽出物を得た。Preparation Example 1 Leaves and twigs of Asunaro are crushed in a speed mill, and the diameter is 2
The powder was passed through a comb that could pass through millimeter particles, and only the crushed material that passed through the core was collected. Next, 5 parts of ethanol was added to 1 part of the pulverized product, and the mixture was extracted for 4 weeks indoors at 25 to 35°C and filtered through a glass filter to obtain a brown extract.
調製例2
アテの葉と小枝をスピードミルにて粉砕し、直径2mm
の粒子を通過ぎせ得る櫛にかけて核部を通過した粉砕物
だけを集めた。次いで該粉砕物1部に対してプロピレン
グリコール3部を加え、20〜40℃の室内で3週間抽
出しガラスフィルター濾過し、緑色の抽出物を得た。Preparation Example 2 Ate leaves and twigs were ground in a speed mill to a diameter of 2 mm.
Only the crushed material that passed through the core was collected by passing it through a comb that could pass through the particles. Next, 3 parts of propylene glycol was added to 1 part of the pulverized product, and the mixture was extracted for 3 weeks indoors at 20 to 40°C and filtered through a glass filter to obtain a green extract.
調製例3
クロベの葉と小枝を自然乾燥後、スピードミルにて粉砕
し、直径2+nmの粒子を通過ぎせ得る櫛にかげて核部
を通過した粉砕物だけを集めた。次いで該粉砕物1部に
対しn−ヘキサン5部を加え、20〜40℃の室内で4
週間抽出しガラスフィルター濾過し、緑色の抽出物を得
た。抽出物からn−ヘキサンを留去させ濃緑色の粘稠物
を得た。Preparation Example 3 After air-drying Arborvitae leaves and twigs, they were ground in a speed mill, passed through a comb that could pass particles with a diameter of 2+ nm, and only the ground material that had passed through the core was collected. Next, 5 parts of n-hexane was added to 1 part of the pulverized material, and the mixture was heated in a room at 20 to 40°C for 4 hours.
The extract was extracted for a week and filtered through a glass filter to obtain a green extract. N-hexane was distilled off from the extract to obtain a dark green viscous substance.
次に上記のようにして得た植物抽出物の抗菌活性、防臭
消臭効果について以下に示す。Next, the antibacterial activity and deodorizing effect of the plant extract obtained as described above will be described below.
試験例1 抗菌活性
培地としてABCM培地(栄研)を用い、オートクレー
ブで115℃、15分間加熱処理した。Test Example 1 ABCM medium (Eiken) was used as an antibacterial activity medium, and heat treated in an autoclave at 115°C for 15 minutes.
各試料の10%アセトン溶液0.05m1を口紙ディス
ク(8mmφ)に浸み込ませ、予めプロピオニバクテリ
ウムアビダム(Propionibacterium
avidum。Soak 0.05 ml of 10% acetone solution of each sample into a mouthpiece disc (8 mmφ), and preliminarily prepare Propionibacterium avidum
avidum.
ATCC2557?)を接種分散した寒天平板上に接着
きせ、37℃3日間嫌気培養した。培養終了時口紙の周
囲に生じる透明帯(プロピオニバクテリウムアビダム発
育阻止帯)の直径を測定し、抗菌力を判定した。ATCC2557? ) was inoculated and dispersed on an agar plate and cultured anaerobically at 37°C for 3 days. At the end of the culture, the diameter of the pellucid zone (Propionibacterium avidum growth inhibition zone) formed around the opening was measured, and the antibacterial activity was determined.
結果を第1表に示す。The results are shown in Table 1.
第 1 表
調製例1の抽出物 18
調製例2の抽出物 20
調製例3の抽出物 28
実施例1:化粧水
一配イリ友公−−%−
(1)アスナロ抽出物(調製例1 ) 0
.5(2)グリセロール 2.
0(3) 1 、3ブチレンゲリコール
2.0(4)クエン酸ソーダ
0.1(5)エタノール 1
0.0(6)ポリオキシエチレン
オレイルアルコール 0.5(7)パラベン
0.1(8)精製水
残余(製法)
上記成分(1)、(5)、(6)に及び(7)を室温に
て混合溶解し、同じく室温にて混合溶解した成分(2)
、(3)、(4)及び(8)中は攪拌添加して化粧水を
得た。Table 1 Extract of Preparation Example 1 18 Extract of Preparation Example 2 20 Extract of Preparation Example 3 28 Example 1: Lotion Ichisei Iri Tomoko --%- (1) Asunaro extract (Preparation Example 1) 0
.. 5(2) Glycerol 2.
0(3) 1,3 butylene gellicol
2.0(4) Sodium citrate
0.1 (5) Ethanol 1
0.0(6) Polyoxyethylene oleyl alcohol 0.5(7) Paraben 0.1(8) Purified water
Residue (manufacturing method) Component (2) obtained by mixing and dissolving the above components (1), (5), (6), and (7) at room temperature, and also mixing and dissolving at room temperature.
, (3), (4) and (8) were added with stirring to obtain a lotion.
比較例1:化粧水
実施例1において成分(1)のアスナロ抽出物を除いた
以外は、全て実施例1と同様にして化粧水を得た。Comparative Example 1: Lotion A lotion was obtained in the same manner as in Example 1 except that the Asunaro extract as component (1) was removed.
実施例1及び比較例1の化粧水のプロピオニバクテリウ
ム アクネスに対する抗菌効果を以下のようにして測定
した。The antibacterial effects of the lotions of Example 1 and Comparative Example 1 against Propionibacterium acnes were measured as follows.
培地にニッスイ社製GAM寒天培地を用いpH7,3±
0.1に調整後、オートクレーブで115℃15分間加
熱処理し平板寒天を得た。試料0.05mtを直径8m
mの濾紙上にとり、予めプロピオニバクテリウムアクネ
ス標準菌株(ATCC11827)を接種分散させたG
AM寒天寒天上地上着させ、37℃、3日間嫌気培養を
行ない、培養終了時濾紙の周囲に生じる透明帯(プロピ
オニバクテリウム アクネス発育防止帯)直径を測定し
、抗菌力を判定した。Nissui's GAM agar medium was used as the medium, pH 7.3±
After adjusting the temperature to 0.1, it was heated in an autoclave at 115°C for 15 minutes to obtain agar plate. Sample 0.05m in diameter 8m
M filter paper and inoculated and dispersed with Propionibacterium acnes standard strain (ATCC11827) in advance.
The samples were placed on AM agar and cultured anaerobically at 37°C for 3 days. At the end of the culture, the diameter of the transparent zone (propionibacterium acnes growth prevention zone) formed around the filter paper was measured to determine the antibacterial activity.
結果を第2表に示す。The results are shown in Table 2.
発育防止帯(mm) 16 9第2表の
結果から明らかなように、アスナロ抽出物を配合した実
施例1は発育防止帯直径が比較例1のそれよりも大きく
抗菌力が強いことを示している。Growth prevention zone (mm) 16 9 As is clear from the results in Table 2, Example 1 containing Asunaro extract has a larger growth prevention zone diameter than that of Comparative Example 1, indicating that it has stronger antibacterial activity. There is.
(以下余白)
実施例2:クレンジングフオーム
ー配」す1分−j
(1)アテ抽出物(調製例2 ) 0
.5(2)グリセリン 18
.0(3)パルミチン酸 10
.0(4)ステアリン酸 10
.0(5)ミリスチン酸 1
2.0(6)ラウリン酸 4
.0(7)オレイルアルコール 1.
0(8)水酸化カリウム 6.0
(9)精製水 残余(製
法)
上記成分(9)に成分(8)を加えて加熱し、これに成
分(2)を添加してただちに70℃に加熱した後、同時
に予め加熱融解してあった成分(1) (3) (4)
(5)(6)及び(7)をかきまぜながら徐々に加え
た。添加後、暫<70℃程度の温度に保ち、けん化反応
を終了きせてクレンジングフオームを得た。(Left below) Example 2: Cleansing foam formulation 1 minute (1) Ate extract (Preparation example 2) 0
.. 5(2) Glycerin 18
.. 0(3) Palmitic acid 10
.. 0(4) Stearic acid 10
.. 0 (5) myristic acid 1
2.0(6) Lauric acid 4
.. 0(7) Oleyl alcohol 1.
0(8) Potassium hydroxide 6.0
(9) Purified water Remaining water (manufacturing method) Component (8) is added to component (9) above and heated. Component (2) is added to this and immediately heated to 70°C. Ingredients (1) (3) (4)
(5) (6) and (7) were gradually added while stirring. After the addition, the temperature was kept at about <70°C for a while to complete the saponification reaction and obtain a cleansing foam.
実施例3:アクネクリーム
一固金皮光−−%−
(1)クロベ抽出物(調製例3) 0.1
(2)感光素201 0.0
03(3)1.3ブチレングリコール
5.0(4)ミツロウ 2
.0(5)セタノール 4
.0(6)還元ラノリン 10
.0(7)スクワラン 30
.0(8)パラベン 0.
2(9)ポリオキシエチレンモノソル
ビタンモノラウリン酸エステル 2.0(10)精製
水 残余(製法)
上記成分(10)に成分(3)を加えて加熱して70℃
に保った(水相部)。他の成分を混合し、加熱溶解して
70℃とした(油相部)。この油相部を水相部に加えて
予備乳化を行ない、ホモミキサーで均一に乳化し、O/
Wクリームを得た。Example 3: Acne Cream Ikki Kinpiko--%- (1) Arborvitae extract (Preparation Example 3) 0.1
(2) Photosensitive element 201 0.0
03(3)1.3 Butylene glycol
5.0 (4) Beeswax 2
.. 0(5) Setanol 4
.. 0(6) Reduced lanolin 10
.. 0(7) Squalane 30
.. 0(8) Paraben 0.
2 (9) Polyoxyethylene monosorbitan monolauric acid ester 2.0 (10) Purified water Remainder (manufacturing method) Add component (3) to the above component (10) and heat to 70°C
(aqueous phase). Other components were mixed and heated to 70° C. (oil phase). This oil phase is added to the aqueous phase for preliminary emulsification, uniformly emulsified with a homomixer, and O/
I got W cream.
実施例4:パック ー配イU友分−j (1)アスナロ抽出物(調製例1) f、。Example 4: Pack -Distribution U friend-j (1) Asunaro extract (Preparation Example 1) f.
(2)酢酸ビニル樹脂エマルジョン 12.0(
3)ポリビニルアルコール 10.0(
4)オリーブ油 3.0(5
)ソルビット 5.0(6)
酸化チタン 15.0(7)
エタノール 10.0(8)
パラベン 0.1(9)精
製水 残余(製法)
上記成分(9)に成分(5)を混合し、それに成分(6
)及び(2)を添加し、更に成分(3)を成分(7)の
一部で湿潤したものを添加し、70℃に加熱して溶解し
た。次に残りの成分(7)に成分(1)及び(8)を加
えて混合し、最後に成分(4)を添加し、冷却してパッ
クを得た。(2) Vinyl acetate resin emulsion 12.0 (
3) Polyvinyl alcohol 10.0 (
4) Olive oil 3.0 (5)
) Sorvit 5.0 (6)
Titanium oxide 15.0 (7)
Ethanol 10.0 (8)
Paraben 0.1 (9) Purified water Residue (manufacturing method) Mix component (5) with component (9) above, add component (6)
) and (2) were added, and component (3) moistened with a portion of component (7) was further added, and the mixture was heated to 70° C. to dissolve. Next, components (1) and (8) were added to the remaining component (7) and mixed, and finally component (4) was added and cooled to obtain a pack.
実施例5:ファンデーション
−」旺治す炎勿−11t
(1)アテ抽出物(調製例2 ) 0.
2(2)酸化チタン 13.
0(3)コロイダルカオリン 25.0
(4)タルク 44.7
(5)ベンガル 0.8(
6)黄酸化鉄 2.5(7)
黒酸化鉄 0.1(8)流
動パラフィン 8.0(9)セス
キオレイン酸ソルビタン 3.5(10)グリ
セリン 2.0(11)パラベ
ン 0.2(製法)
上記成分(5)〜(7)を混合し、粉砕機を通して平均
粒径1〜5μmに粉砕した。これを高速ブレンダーに移
し、成分(10)を加えて混合した。別に成分(1)、
(8)、(9)及び(11)を混合し、均一にしたもの
を上記混合物に加えて更に均一に混合した。Example 5: Foundation - "Healing Flames - 11t" (1) Ate Extract (Preparation Example 2) 0.
2(2) Titanium oxide 13.
0(3) Colloidal Kaolin 25.0
(4) Talc 44.7
(5) Bengal 0.8 (
6) Yellow iron oxide 2.5 (7)
Black iron oxide 0.1 (8) Liquid paraffin 8.0 (9) Sorbitan sesquioleate 3.5 (10) Glycerin 2.0 (11) Paraben 0.2 (Production method) Above components (5) to (7) were mixed and pulverized through a pulverizer to an average particle size of 1 to 5 μm. This was transferred to a high-speed blender, and component (10) was added and mixed. Separately, component (1),
(8), (9) and (11) were mixed and homogenized, and the resulting mixture was added to the above mixture and further mixed uniformly.
これを粉砕機で処理し、ふるいを通し粒度を揃えた後、
圧縮成型し、ケーキ型ファンデーションを得た。After processing this in a crusher and passing it through a sieve to equalize the particle size,
Compression molding was performed to obtain a cake-shaped foundation.
: : ユミ
頭皮に常在する酵母ピティロスボラム オパール(Pi
tyrosporu+++ ovale)は頭皮の脂質
を分解し脂肪酸を生成する。この脂肪酸は頭皮に紅斑や
カユミをあたえる。更に、これに対する生態の防御反応
として皮膚のターンオーバーの加速がはじまり、この結
果表皮角化層の剥離堆積をきたし、フケを発生する。こ
れらのことからビティロスボラム オパールの活性を阻
止又は偶力化すればフケ・カユミを防止することができ
る。ピティロスポラム オパールにたいするクロベ抽出
物の抗菌力を検討した。: : Yeast Pityrosvorum Opal (Pi
tyrosporu +++ ovale) decomposes lipids in the scalp and produces fatty acids. This fatty acid causes erythema and itching on the scalp. Furthermore, as an ecological defense reaction against this, skin turnover begins to accelerate, resulting in exfoliation and accumulation of the epidermal cornified layer, resulting in dandruff. Based on these facts, dandruff and itching can be prevented by blocking or combining the activity of Vityrosvorum opal. The antibacterial activity of arborvitae extract against Pityrosporum opal was investigated.
(1)クロベ抽出物(調製例1)5
(2)アセトン 残量(1
)を(2)に添加溶解して5駕クロベ抽出物アセトン溶
液を得た。この溶液をアセトンで希釈し、 C
0,625Xまでの各種濃度のりaべ抽出物アセトン溶
液を得た。(1) Arborvitae extract (preparation example 1) 5 (2) Acetone remaining amount (1
) was added and dissolved in (2) to obtain a 5-cup arborvitae extract acetone solution. This solution was diluted with acetone to obtain Nori abe extract acetone solutions of various concentrations up to C 0,625X.
°° ・ ユミ の;′−
培地(ポテトエキス2%、酵母エキスIX、ペプトンI
L オリーブ油3駕、寒天2駕)を100シフラスコに
入れ、オートクレーブで121℃15分間加熱処理した
。更に調整した各濃度の試験液(i)のアセトン溶液を
11nt加え平板を作成した。これにピティロスボラム
オパール標準菌株(IFo 0656)を接種し、3
7℃48時間静置培養を行ない、培養終了時の菌体の生
育の有無を観察し、菌体が生育阻止できる最小濃度を判
定した。この濃度を旧Cとした。°° Yumi's;'- medium (potato extract 2%, yeast extract IX, peptone I
3 volumes of L olive oil and 2 volumes of agar) were placed in a 100-shelf flask and heat-treated at 121°C for 15 minutes in an autoclave. Furthermore, 11 nt of an acetone solution of the test solution (i) of each adjusted concentration was added to prepare a flat plate. Pityrosvorum opal standard strain (IFo 0656) was inoculated into this, and 3
Static culture was carried out at 7°C for 48 hours, and the presence or absence of bacterial cell growth was observed at the end of the culture to determine the minimum concentration that could inhibit bacterial cell growth. This concentration was designated as old C.
上記試験において、クロベ抽出物の代りに1χジンクピ
リチオン、もしくは1χヒノキチオールに変え、それ以
外は全て同様にして対照試験液を得、同様にしてMIC
を求めた。In the above test, 1χ zinc pyrithione or 1χ hinokitiol was used instead of arborvitae extract, and a control test solution was obtained in the same manner except for MIC.
I asked for
結果を第3表に示す。The results are shown in Table 3.
1−2−」艷
実施例 クロベ抽出物 200対照例 ジン
クピリチオン 50第3表の結果から明らかなよう
にクロベ抽出物は現在一般的に使用されているフケ防止
用薬剤の抗菌効果には劣るものの植物抽出物としては強
いフケ防止剤であることがわかる。1-2-” Arborvitae extract 200 Control example Zinc pyrithione 50 As is clear from the results in Table 3, arborvitae extract is inferior to the anti-dandruff drugs commonly used in anti-dandruff drugs at present, but it is still effective as a plant. As an extract, it is found to be a strong anti-dandruff agent.
実施例6:ヘアトニック
至金皿立 X
(1)アスナロ抽出物(調製例1 ) 2.0
(2)センブリ流エキス 0.5(3
)サリチル酸 0.3(4)エチ
ニルエストラジオール 0.0005(5)パ
ントテニールエチルエーテル 0.1(6)エタノ
ール 40.0(7)精製水
残余(製法)
上記成分(6)に(1)、(3)、(4)及び(5)を
加えて室温で混合溶解し、同じく室温にて混合溶解した
成分(7)と(2)を先に@Mした(6)中へ撹拌添加
してヘアトニックを得た。Example 6: Hair Tonic Shikin Saratachi X (1) Asunaro extract (Preparation Example 1) 2.0
(2) Assemble style extract 0.5 (3
) Salicylic acid 0.3 (4) Ethinyl estradiol 0.0005 (5) Pantothenyl ethyl ether 0.1 (6) Ethanol 40.0 (7) Purified water
Residue (manufacturing method) Add (1), (3), (4) and (5) to the above component (6), mix and dissolve at room temperature, and add components (7) and (2) that were also mixed and dissolved at room temperature. A hair tonic was obtained by stirring and adding the mixture to (6) which had been previously @Med.
比較例2:ヘアトニック
実施例6において成分(1)のアスナロ抽出物を配合し
なかった以外は実施例6と同様にして調整し、以下の評
価試験に使用した。Comparative Example 2: Hair Tonic A hair tonic was prepared in the same manner as in Example 6, except that the Asunaro extract as component (1) was not blended in, and used in the following evaluation test.
フケ症あるいはフケの出やすい大30名の中より視感判
定によりフケの多い人を10名選び、使用テストパネル
とした。この10名を5名づつ2群に分け、A群、B群
とし、A群には実施例6のヘアトニックをB群には比較
例2のヘアトニックを使用させた。使用条件及び判定は
次のように行った。Out of 30 people who had dandruff or were prone to dandruff, 10 people who had a lot of dandruff were selected by visual judgment to serve as test panels. These 10 people were divided into two groups of 5 people each, group A and group B. Group A used the hair tonic of Example 6, and group B used the hair tonic of Comparative Example 2. The conditions of use and evaluation were as follows.
即ち、A、B両群とも3日おきにフケ防止剤等の薬剤を
含まないシャンプーで洗髪を繰り返し、洗髪直前にフケ
の量を視感判定したところ、5回のシャンプーの間フケ
量はかなり、多く、A、B両群間にも、パネル個々の間
にも明らかな差は認められなかった。そこで次の日から
各群ともそれぞれのヘアトニックを1日1回頭皮につけ
ることとし、それまでと同様のサイクルで3日おきに洗
髪、視感判定を繰り返した。結果を第4表に示す。In other words, both groups A and B repeatedly washed their hair every 3 days with a shampoo that does not contain drugs such as anti-dandruff agents, and visually judged the amount of dandruff just before washing their hair. However, there were no obvious differences between groups A and B or between individual panels. Therefore, starting from the next day, each group applied their respective hair tonics to their scalps once a day, and repeated the same cycle of hair washing and visual evaluation every three days. The results are shown in Table 4.
(以下余白)
1 ピ
第4表
実施例7:シャンプー
y金度分 差
(1)アテ抽出物(調製例2 ) 2.0
(2) P OE−アルキル硫酸塩 10.
0(3)ラウリン酸ジェタノールアミド 10.0(
4)プロピレングリコール 2.0(5)
パラベン 0.2(6)精製
水 残余(製法)
上記成分(2)と(3)を60℃で加熱溶解した中は(
6)を添加し、更に混合溶解した(1)、(4)及び(
5)を撹拌添加してシ、ヤンブーを得た。(Left below) 1 Pi Table 4 Example 7: Shampoo y Gold Difference (1) Ate extract (Preparation example 2) 2.0
(2) POE-alkyl sulfate 10.
0(3) Lauric acid jetanolamide 10.0(
4) Propylene glycol 2.0 (5)
Paraben 0.2 (6) Purified water Residue (manufacturing method) Ingredients (2) and (3) above were dissolved by heating at 60℃ (
6) was added and further mixed and dissolved (1), (4) and (
5) was added with stirring to obtain Shi and Yanbu.
実施例8:クリツム
−L合度分−1
(1)アテ抽出物(調製例2 ) 1.
0(2)流動パラフィン 10.0
(3) 1 、3ブチレングリコール
5.0(4)ミツミラ 2.
0(5)セタノール 4,0
(6)還元ラノリン 2.0
(7)スクワラン 30.0
(8)パラベン 0.2(
9)ポリオキシエチレンモノソル
ビタンモノラウリン酸エステル 2.0(10)精製
水 残余(製法)
上記成分(10)に成分(1)、(3)を加えて加熱し
て70℃に保った(水相部)。他の成分を混合し、加熱
溶解して70℃とした(油相部)。この油相部を水相部
に加えて予備乳化を行ない、ホモミキサーで均一に乳化
し、0/Wクリームを得た。Example 8: Chrytum-L degree-1 (1) Ate extract (Preparation example 2) 1.
0(2) Liquid paraffin 10.0
(3) 1,3 butylene glycol
5.0 (4) Mitsumira 2.
0(5) Setanol 4,0
(6) Reduced lanolin 2.0
(7) Squalane 30.0
(8) Paraben 0.2 (
9) Polyoxyethylene monosorbitan monolaurate 2.0 (10) Purified water Residue (manufacturing method) Components (1) and (3) were added to the above component (10) and heated and kept at 70°C (water phase Department). Other components were mixed and heated to 70° C. (oil phase). This oil phase was added to the aqueous phase for preliminary emulsification, and the mixture was uniformly emulsified using a homomixer to obtain a 0/W cream.
実施例9:乳液
−n金度分−−%−
(1)クロベ抽出物(調製例3 ) 0.
5(2)流動パラフィン 10.
0(3)ワセリン 4.0
(4)ステアリン酸 2.0(
5)セタノール 1.0(6
)グリセリルモノステアリン酸
エステル(自己乳化型)2.0
(7)プロピレングリコール 7.0(
8)精製水 残余(9)水
酸化ナトリウム 0.4(製法)
(1)ないしく6)を混合し、加熱溶解後70℃に保つ
(油相)。(7)ないしく9)を混合溶解後、加熱し7
0℃に保つ(水相)。油相を水相に加え、その後ホモミ
キサーで均一に乳化し、よくかきまぜながら30℃まで
冷却する。Example 9: Emulsion-n gold degree--%- (1) Arborvitae extract (Preparation Example 3) 0.
5(2) Liquid paraffin 10.
0(3) Vaseline 4.0
(4) Stearic acid 2.0 (
5) Setanol 1.0 (6
) Glyceryl monostearate (self-emulsifying type) 2.0 (7) Propylene glycol 7.0 (
8) Purified water Remainder (9) Sodium hydroxide 0.4 (manufacturing method) Mix (1) or 6) and maintain at 70°C after heating and dissolving (oil phase). After mixing and dissolving (7) or 9), heat 7
Keep at 0°C (aqueous phase). The oil phase is added to the aqueous phase, then uniformly emulsified using a homomixer, and cooled to 30°C while stirring well.
実施例10:油性軟膏
−n丘瓜立−1
(1)クロベ抽出物(調製例31 0.5(
2)ショートニングオイル 3.0(3
)ワセリン 96.5(製
法)
上記成分を混合し、80℃まで加温し、徐々に冷却する
。Example 10: Oil-based ointment-n-Kuuridate-1 (1) Arborvitae extract (Preparation Example 31 0.5 (
2) Shortening oil 3.0 (3
) Vaseline 96.5 (Production method) The above ingredients are mixed, heated to 80°C, and gradually cooled.
Claims (1)
に属する植物の抽出物を含有してなる皮膚外用剤。(1) A skin external preparation containing an extract of a plant belonging to the genus Asunaro, arborvitae, or juniper in the family Cupressaceae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61295874A JPS63150208A (en) | 1986-12-12 | 1986-12-12 | External drug for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61295874A JPS63150208A (en) | 1986-12-12 | 1986-12-12 | External drug for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63150208A true JPS63150208A (en) | 1988-06-22 |
Family
ID=17826294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61295874A Pending JPS63150208A (en) | 1986-12-12 | 1986-12-12 | External drug for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63150208A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200429A (en) * | 1990-09-28 | 1993-04-06 | Takasago International Corporation | Acne vulgaris treating |
WO1994023732A1 (en) * | 1993-04-08 | 1994-10-27 | Kambourakis Medicinal Solutions Pty. Limited | Therapeutic preparations containing cypress tree extracts and methods of using same |
JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | Skin preparation for external use |
JPH09255548A (en) * | 1996-03-22 | 1997-09-30 | Kao Corp | Wrinkling suppressing agent |
WO1997035557A1 (en) * | 1996-03-22 | 1997-10-02 | Kao Corporation | External skin-care composition |
KR100438007B1 (en) * | 2001-09-10 | 2004-06-30 | 한불화장품주식회사 | A cosmetic composition containing an extract of juniperus chinensis |
KR100441131B1 (en) * | 2001-08-22 | 2004-07-21 | 애경산업(주) | Cosmetic compositons for acne skin containing natural fragrant oil |
KR100521784B1 (en) * | 2002-07-23 | 2005-10-14 | 주식회사 내츄로바이오텍 | Composition containing extract derived from natural products that have growth-inhibition activity against dandruff causing microorganism |
KR100941133B1 (en) | 2009-03-19 | 2010-02-09 | 주식회사 코스메카코리아 | Cosmetic composition |
-
1986
- 1986-12-12 JP JP61295874A patent/JPS63150208A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5200429A (en) * | 1990-09-28 | 1993-04-06 | Takasago International Corporation | Acne vulgaris treating |
WO1994023732A1 (en) * | 1993-04-08 | 1994-10-27 | Kambourakis Medicinal Solutions Pty. Limited | Therapeutic preparations containing cypress tree extracts and methods of using same |
JPH09165313A (en) * | 1995-12-15 | 1997-06-24 | Kao Corp | Skin preparation for external use |
JPH09255548A (en) * | 1996-03-22 | 1997-09-30 | Kao Corp | Wrinkling suppressing agent |
WO1997035557A1 (en) * | 1996-03-22 | 1997-10-02 | Kao Corporation | External skin-care composition |
KR100441131B1 (en) * | 2001-08-22 | 2004-07-21 | 애경산업(주) | Cosmetic compositons for acne skin containing natural fragrant oil |
KR100438007B1 (en) * | 2001-09-10 | 2004-06-30 | 한불화장품주식회사 | A cosmetic composition containing an extract of juniperus chinensis |
KR100521784B1 (en) * | 2002-07-23 | 2005-10-14 | 주식회사 내츄로바이오텍 | Composition containing extract derived from natural products that have growth-inhibition activity against dandruff causing microorganism |
KR100941133B1 (en) | 2009-03-19 | 2010-02-09 | 주식회사 코스메카코리아 | Cosmetic composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3911991B2 (en) | Active oxygen scavenger and cosmetics | |
JPH0940523A (en) | Fibroblast proliferation promoter containing water extract form chlorella | |
JPH0624937A (en) | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic | |
JPH1045615A (en) | Plant extract-containing fibroblast growth promoter | |
JPH1053532A (en) | Antiallergic drug containing plant extract | |
KR20090098732A (en) | Anti-inflammatory, anti-oxidative or anti-bacterial compositions | |
JPH09157176A (en) | Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim. | |
JP2000169383A (en) | Antiallergic agent | |
JPS63192705A (en) | External agent for skin | |
JPS6248611A (en) | External preparation for skin | |
JPH0987189A (en) | Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne | |
JPS63150208A (en) | External drug for skin | |
JPS61238719A (en) | Hair cosmetic | |
JP2000143524A (en) | Antiinflammatory agent containing extract of amaranthus | |
KR101347910B1 (en) | a Food Composition, a Cosmetic Composition, a Pharmaceutical Composition Comprising Supercritical Fluid Extract of Ginger and Extract of Dropwort Fermented | |
JP2002212009A (en) | Antifungal agent and antimicrobial low-irritative cosmetic comprising the same | |
JPH08283143A (en) | Skin preparation for external use | |
JPH0532556A (en) | Skin agent for external use | |
JP2001114636A (en) | Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion | |
KR101681258B1 (en) | Natural shampoo composition comprising plant extracts and natural surfactant | |
JP2003183175A (en) | alpha-MSH INHIBITOR ORIGINATING FROM TEA EXTRACT AND WHITENING AGENT, ANTI-AGING AGENT AND MMP-1 PRODUCTION INHIBITOR CONTAINING THE SAME, AND SKIN CARE PREPARATION CONTAINING THESE | |
JP2001139489A (en) | Cosmetic composition | |
JP3319870B2 (en) | Skin external composition and bath agent | |
JPS63119410A (en) | Skin drug for external use | |
JPS61205204A (en) | External preparation for skin |